US Stock MarketDetailed Quotes

MEDP Medpace

Watchlist
  • 340.175
  • -2.235-0.65%
Close Feb 14 16:00 ET
  • 340.175
  • 0.0000.00%
Post 20:01 ET
10.36BMarket Cap26.93P/E (TTM)

Medpace Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
40.48%608.82M
21.91%190.67M
30.33%149.08M
41.06%116.4M
90.67%152.68M
11.68%433.37M
14.42%156.4M
5.43%114.39M
-14.59%82.52M
73.11%80.08M
Net income from continuing operations
42.99%404.39M
49.45%117.02M
36.68%96.43M
44.68%88.35M
40.74%102.59M
15.26%282.81M
14.02%78.3M
6.85%70.55M
23.72%61.07M
18.89%72.89M
Depreciation and amortization
11.10%29.25M
7.66%7.51M
9.31%7.52M
10.97%7.24M
17.35%6.99M
17.85%26.33M
18.19%6.97M
18.81%6.88M
17.58%6.52M
16.64%5.96M
Deferred tax
-6.03%-26.63M
-75.24%-24.2M
80.08%-1.51M
97.96%-54K
18.63%-865K
-9.14%-25.12M
33.89%-13.81M
-1,006.11%-7.6M
-264.46%-2.65M
-49.09%-1.06M
Other non cash items
-14.48%19.12M
-18.77%5.65M
-10.98%5.91M
11.62%6.09M
-55.60%1.47M
40.68%22.35M
150.22%6.95M
38.80%6.64M
29.67%5.46M
-19.80%3.3M
Change In working capital
47.61%157.18M
8.22%78.81M
-11.86%29.01M
55.09%11.19M
691.71%38.18M
0.41%106.49M
-2.43%72.82M
22.87%32.91M
-77.86%7.21M
76.90%-6.45M
-Change in receivables
104.64%2.24M
270.32%15.27M
41.31%-10.32M
-25.53%-21.83M
540.06%19.12M
27.85%-48.28M
-100.09%-8.97M
24.80%-17.58M
-1,982.63%-17.39M
88.64%-4.34M
-Change in prepaid assets
-504.89%-12.09M
-108.22%-982K
-95.03%143K
-25.83%-2.05M
9.80%-9.21M
129.35%2.99M
65.33%11.94M
106.68%2.88M
87.72%-1.63M
-83.97%-10.21M
-Change in payables and accrued expense
-83.26%13.92M
-89.66%3.01M
-59.08%12.44M
-5.48%26.95M
-480.46%-28.48M
41.12%83.13M
183.11%29.13M
-0.07%30.4M
24.56%28.51M
-4.58%-4.91M
-Change in other current liabilities
-13.43%-21.41M
-34.91%-5.99M
13.10%-4.39M
-24.03%-5.08M
-12.53%-5.95M
-18.71%-18.87M
6.82%-4.44M
-47.39%-5.05M
1.63%-4.1M
-49.18%-5.28M
-Change in other working capital
99.40%174.52M
49.46%67.49M
39.83%31.13M
626.60%13.2M
242.87%62.7M
-37.55%87.52M
-31.96%45.16M
2.24%22.26M
-93.50%1.82M
-24.01%18.29M
Cash from discontinued investing activities
Operating cash flow
40.48%608.82M
21.91%190.67M
30.33%149.08M
41.06%116.4M
90.67%152.68M
11.68%433.37M
14.42%156.4M
5.43%114.39M
-14.59%82.52M
73.11%80.08M
Investing cash flow
Cash flow from continuing investing activities
18.25%-28.31M
5.44%-7.56M
-21.06%-10.49M
-51.06%-12.79M
126.62%2.53M
10.62%-34.63M
13.26%-8M
-20.52%-8.66M
23.91%-8.47M
15.21%-9.5M
Net PPE purchase and sale
0.27%-36.55M
23.46%-7.64M
----
----
42.22%-5.5M
0.63%-36.65M
-8.04%-9.99M
----
----
---9.51M
Net other investing changes
308.12%8.24M
-95.93%81K
24.39%51K
485.71%81K
80,170.00%8.03M
208.37%2.02M
8,547.83%1.99M
612.50%41K
-128.77%-21K
100.51%10K
Cash from discontinued investing activities
Investing cash flow
18.25%-28.31M
5.44%-7.56M
-21.06%-10.49M
-51.06%-12.79M
126.62%2.53M
10.62%-34.63M
13.26%-8M
-20.52%-8.66M
23.91%-8.47M
15.21%-9.5M
Financing cash flow
Cash flow from continuing financing activities
15.68%-154.01M
-11,170.85%-168.61M
112.73%6.27M
100.81%666K
114.54%7.66M
76.46%-182.64M
101.16%1.52M
54.84%-49.27M
33.41%-82.21M
87.22%-52.68M
Net issuance payments of debt
--0
--0
--0
--0
--0
-200.00%-50M
--0
50.00%-55M
-124.03%-60M
--65M
Net common stock issuance
-17.95%-169.87M
---169.87M
--0
--0
--0
83.01%-144.02M
--0
--0
93.63%-23.87M
71.79%-120.15M
Proceeds from stock option exercised by employees
39.37%15.86M
-17.40%1.26M
9.53%6.27M
-59.98%666K
211.00%7.66M
-48.46%11.38M
-73.56%1.52M
542.15%5.73M
7.08%1.66M
-82.24%2.46M
Cash from discontinued financing activities
Financing cash flow
15.68%-154.01M
-11,170.85%-168.61M
112.73%6.27M
100.81%666K
114.54%7.66M
76.46%-182.64M
101.16%1.52M
54.84%-49.27M
33.41%-82.21M
87.22%-52.68M
Net cash flow
Beginning cash position
768.38%245.45M
589.97%656.9M
1,205.37%510.89M
767.42%407.01M
768.38%245.45M
-93.87%28.27M
207.05%95.21M
-8.02%39.14M
-43.36%46.92M
-93.87%28.27M
Current changes in cash
97.36%426.5M
-90.33%14.5M
156.62%144.86M
1,378.01%104.27M
810.38%162.87M
150.67%216.1M
4,199.56%149.92M
823.36%56.45M
78.51%-8.16M
104.74%17.89M
Effect of exchange rate changes
-332.28%-2.51M
-710.28%-1.96M
399.21%1.14M
-203.73%-389K
-270.27%-1.31M
116.45%1.08M
-64.92%321K
89.79%-382K
116.16%375K
153.79%767K
End cash Position
172.74%669.44M
172.74%669.44M
589.97%656.9M
1,205.37%510.89M
767.42%407.01M
768.38%245.45M
768.38%245.45M
207.05%95.21M
-8.02%39.14M
-43.36%46.92M
Free cash flow
44.25%572.27M
25.01%183.02M
31.09%138.54M
39.76%103.53M
108.58%147.18M
12.97%396.73M
14.88%146.41M
4.31%105.68M
-13.28%74.07M
90.72%70.56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 40.48%608.82M21.91%190.67M30.33%149.08M41.06%116.4M90.67%152.68M11.68%433.37M14.42%156.4M5.43%114.39M-14.59%82.52M73.11%80.08M
Net income from continuing operations 42.99%404.39M49.45%117.02M36.68%96.43M44.68%88.35M40.74%102.59M15.26%282.81M14.02%78.3M6.85%70.55M23.72%61.07M18.89%72.89M
Depreciation and amortization 11.10%29.25M7.66%7.51M9.31%7.52M10.97%7.24M17.35%6.99M17.85%26.33M18.19%6.97M18.81%6.88M17.58%6.52M16.64%5.96M
Deferred tax -6.03%-26.63M-75.24%-24.2M80.08%-1.51M97.96%-54K18.63%-865K-9.14%-25.12M33.89%-13.81M-1,006.11%-7.6M-264.46%-2.65M-49.09%-1.06M
Other non cash items -14.48%19.12M-18.77%5.65M-10.98%5.91M11.62%6.09M-55.60%1.47M40.68%22.35M150.22%6.95M38.80%6.64M29.67%5.46M-19.80%3.3M
Change In working capital 47.61%157.18M8.22%78.81M-11.86%29.01M55.09%11.19M691.71%38.18M0.41%106.49M-2.43%72.82M22.87%32.91M-77.86%7.21M76.90%-6.45M
-Change in receivables 104.64%2.24M270.32%15.27M41.31%-10.32M-25.53%-21.83M540.06%19.12M27.85%-48.28M-100.09%-8.97M24.80%-17.58M-1,982.63%-17.39M88.64%-4.34M
-Change in prepaid assets -504.89%-12.09M-108.22%-982K-95.03%143K-25.83%-2.05M9.80%-9.21M129.35%2.99M65.33%11.94M106.68%2.88M87.72%-1.63M-83.97%-10.21M
-Change in payables and accrued expense -83.26%13.92M-89.66%3.01M-59.08%12.44M-5.48%26.95M-480.46%-28.48M41.12%83.13M183.11%29.13M-0.07%30.4M24.56%28.51M-4.58%-4.91M
-Change in other current liabilities -13.43%-21.41M-34.91%-5.99M13.10%-4.39M-24.03%-5.08M-12.53%-5.95M-18.71%-18.87M6.82%-4.44M-47.39%-5.05M1.63%-4.1M-49.18%-5.28M
-Change in other working capital 99.40%174.52M49.46%67.49M39.83%31.13M626.60%13.2M242.87%62.7M-37.55%87.52M-31.96%45.16M2.24%22.26M-93.50%1.82M-24.01%18.29M
Cash from discontinued investing activities
Operating cash flow 40.48%608.82M21.91%190.67M30.33%149.08M41.06%116.4M90.67%152.68M11.68%433.37M14.42%156.4M5.43%114.39M-14.59%82.52M73.11%80.08M
Investing cash flow
Cash flow from continuing investing activities 18.25%-28.31M5.44%-7.56M-21.06%-10.49M-51.06%-12.79M126.62%2.53M10.62%-34.63M13.26%-8M-20.52%-8.66M23.91%-8.47M15.21%-9.5M
Net PPE purchase and sale 0.27%-36.55M23.46%-7.64M--------42.22%-5.5M0.63%-36.65M-8.04%-9.99M-----------9.51M
Net other investing changes 308.12%8.24M-95.93%81K24.39%51K485.71%81K80,170.00%8.03M208.37%2.02M8,547.83%1.99M612.50%41K-128.77%-21K100.51%10K
Cash from discontinued investing activities
Investing cash flow 18.25%-28.31M5.44%-7.56M-21.06%-10.49M-51.06%-12.79M126.62%2.53M10.62%-34.63M13.26%-8M-20.52%-8.66M23.91%-8.47M15.21%-9.5M
Financing cash flow
Cash flow from continuing financing activities 15.68%-154.01M-11,170.85%-168.61M112.73%6.27M100.81%666K114.54%7.66M76.46%-182.64M101.16%1.52M54.84%-49.27M33.41%-82.21M87.22%-52.68M
Net issuance payments of debt --0--0--0--0--0-200.00%-50M--050.00%-55M-124.03%-60M--65M
Net common stock issuance -17.95%-169.87M---169.87M--0--0--083.01%-144.02M--0--093.63%-23.87M71.79%-120.15M
Proceeds from stock option exercised by employees 39.37%15.86M-17.40%1.26M9.53%6.27M-59.98%666K211.00%7.66M-48.46%11.38M-73.56%1.52M542.15%5.73M7.08%1.66M-82.24%2.46M
Cash from discontinued financing activities
Financing cash flow 15.68%-154.01M-11,170.85%-168.61M112.73%6.27M100.81%666K114.54%7.66M76.46%-182.64M101.16%1.52M54.84%-49.27M33.41%-82.21M87.22%-52.68M
Net cash flow
Beginning cash position 768.38%245.45M589.97%656.9M1,205.37%510.89M767.42%407.01M768.38%245.45M-93.87%28.27M207.05%95.21M-8.02%39.14M-43.36%46.92M-93.87%28.27M
Current changes in cash 97.36%426.5M-90.33%14.5M156.62%144.86M1,378.01%104.27M810.38%162.87M150.67%216.1M4,199.56%149.92M823.36%56.45M78.51%-8.16M104.74%17.89M
Effect of exchange rate changes -332.28%-2.51M-710.28%-1.96M399.21%1.14M-203.73%-389K-270.27%-1.31M116.45%1.08M-64.92%321K89.79%-382K116.16%375K153.79%767K
End cash Position 172.74%669.44M172.74%669.44M589.97%656.9M1,205.37%510.89M767.42%407.01M768.38%245.45M768.38%245.45M207.05%95.21M-8.02%39.14M-43.36%46.92M
Free cash flow 44.25%572.27M25.01%183.02M31.09%138.54M39.76%103.53M108.58%147.18M12.97%396.73M14.88%146.41M4.31%105.68M-13.28%74.07M90.72%70.56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025